Company Profiles

driven by the PitchBook Platform

Bicycle Therapeutics

Bicycle Therapeutics
2009 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series B LATEST DEAL TYPE
$51.2M LATEST DEAL AMOUNT
$93.3M TOTAL AMOUNT RAISED
Description

Developer of first in class medicines created to treat cancer and other debilitating diseases. The company's first in class medicines includes bicyclic peptides that combine antibody-like affinity and selectivity with small molecule-like tissue penetration, tuneable exposure, flexible pharmacokinetics and chemical synthesis, exploring the potential of bicyclic peptides as targeted, titratable and rapidly penetrant immunomodulators, overcoming the challenges seen for other agents with long exposure, irreversible effects and attendant toxicities.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
Meditrina Building
Babraham Research Campus
Cambridge CB22 3AT
England

+44 (0)12 2326 1503
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Bicycle Therapeutics’s full profile, request a free trial.

Bicycle Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 27-Jun-2017 $51.2M $93.3M 000.00 Completed Pre-Clinical Trials
4. Early Stage VC (Series A) 03-Oct-2016 00.00 000.00 000.00 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 14-Oct-2014 000.00 000.00 000.00 Completed Pre-Clinical Trials
2. Seed Round 01-Jan-2010 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Bicycle Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
Series A 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
To view this company’s complete Cap Table request access »

Bicycle Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Astellas Venture Management Corporate Venture Capital Minority 000 0000 000000 0
Atlas Venture Venture Capital Minority 000 0000 000000 0
Cambridge Innovation Capital Venture Capital Minority 000 0000 000000 0
Longwood Fund Venture Capital Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Bicycle Therapeutics Executive Team (11)

Name Title Board
Seat
Contact
Info
Kevin Lee Ph.D Chief Executive Officer & Board Member
Rosamond Deegan Chief Business Officer & President
Lee Kalowski Chief Financial Officer
Nick Keen Ph.D Chief Scientific Officer
Alan Watt Ph.D Interim CSO and Head of Therapeutics
You’re viewing 5 of 11 executives. Get the full list »

Bicycle Therapeutics Board Members (13)

Name Representing Role Since Contact
Info
Anja K├Ânig Ph.D Novartis Venture Fund Board Member 000 0000
Catherine Bingham SV Health Investors Board Member 000 0000
Christopher Shen MD Vertex Ventures HC Board Member 000 0000
Deborah Harland Ph.D SR One Board Member 000 0000
Gregory Winter Ph.D Bicycle Therapeutics Co-Founder & Board Member 000 0000

1 Former Board Members

You’re viewing 5 of 13 board members. Get the full list »